CRBU
Caribou Biosciences Inc
0.4602$
-4.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -121.7% | -600.9% | -1,531.6% | -948.8% | -1,613.7% | -1,707.8% | -1,560.8% | -1,059.5% | -1,145.8% | -528.4% | -1,125.7% | -1,520.1% | -954.5% | |
| 6.7% | 20.8% | 29.2% | 24.7% | 58.2% | 57.0% | 49.5% | 43.8% | 28.7% | 17.3% | 27.1% | 41.7% | 25.8% | |
| 14.7% | 99.9% | 164.2% | 136.8% | 201.0% | 188.3% | 165.0% | 117.3% | 133.3% | 69.5% | 98.3% | 165.2% | 104.7% | |
| -93.3% | 141.2% | -35.0% | 82.6% | -139.5% | -207.1% | -63.6% | 20.8% | -64.1% | 47.4% | -206.5% | -125.7% | -63.5% | |
| 20.1% | 64.0% | 121.4% | 68.3% | 33.3% | 24.9% | 44.3% | 15.7% | 5.2% | 5.5% | 3.0% | 0.1% | 4.0% | |
| -289.4% | -884.6% | 945.1% | 612.0% | 1,310.3% | 767.0% | 2,098.6% | 901.2% | 493.7% | 456.0% | 1,000.6% | 1,263.6% | 715.0% | |
| – | -1.2% | 27.5% | – | -33.0% | – | – | – | – | – | – | – | – | |
| 571.1% | -1.2% | 514.0% | 3.8% | 12.1% | 186.0% | 19.9% | 0.2% | 12.6% | 103.3% | 112.5% | 1,196.5% | 248.9% | |
| 160.0% | -1,486.7% | -72.5% | -333.0% | -291.3% | -754.8% | 557.8% | -158.1% | -639.5% | 30.9% | -12.6% | 940.0% | 9.4% | |
| -141.7% | -664.9% | -1,653.0% | -1,017.1% | -1,646.9% | -1,732.7% | -1,605.1% | -1,075.2% | -1,151.0% | -522.9% | -1,128.7% | -1,520.2% | -954.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.